Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women

European Journal of Cancer Prevention

Volumn 16, Issue 6, 2007, Pages 498-504

  Agorastos, Theodoros ^a   Papadopoulos, Nikolaos ^a   Lambropoulos, Alexandros F ^a   Chrisafi, Sofia ^a   Mikos, Themistoklis ^a   Goulis, Dimitrios G ^a   Constantinidis, Theodoros C ^b   Kotsis, Alexandros ^a   Bontis, John N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cervical intraepithelial neoplasia; Cigarette smoking; CYP1A1; GSTM1; GSTT1; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GREECE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; MUTATIONAL ANALYSIS; NULL ALLELE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING HABIT; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WILD TYPE;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; GREECE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 37349113340     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000243859.99265.92     Document Type: Article

References (27)

1. Abba MC, Villaverde LM, Gomez MA, Dulout FN, Laguens MR, Golijow CD (2003). The p53 codon genotypes in HPV infection and cervical disease. Eur J Obstet Gynecol Reprod Biol 109:63-66.
2. Agorastos T, Dinas K, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, de Sanjose S (2004). Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece. Eur J Cancer Prev 13:145-147.
3. Agorastos T, Lampropoulos AF, Constadinidis TC, Kotsis A, Bontis J (2000). p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 9:113-118.
4. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Kriek E, Bartsch H (2002). CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 23:1969-1977.
5. Alonio LV, Picconi MA, Dalbert D, Mural J, Bartt O, Bazan G, et al. (2003). Ha-ras oncogène mutation associated to progression of papillomavirus induced lesions of uterine cervix. J Clin Virol 27:263-269.
6. Chen C, Madeleine MM,Weiss NS, Daling JR (1999). Glutathione S transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study. Am J Epidemiol 150:568-572.
7. Coles BF, Kadlubar FF (2005). Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401:9-42.
8. Dialyna IA, Miyakis S, Georgatou N, Spandidos DA (2003). Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol Rep 10:1829-1835.
9. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev 10:1239-1248.
10. Goodman MT, McDuffie K, Hernandez B, Bertram CC,Wilkens LR, Guo C, et al. (2001). CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81:263-269.
11. Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, et al. (2003). Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 89:2078-2086.
12. Hadfield RM, Manek S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH; OXEGENE Collaborative Group (2001). Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 7:1073-1078.
13. zur Hausen H (1999). Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9:405-411.
14. Haverkos HW, Soon G, Steckley SL, Pickworth W (2003). Cigarette smoking and cervical cancer: Part I: a meta-analysis. Biomed Pharmacother 57:67-77.
15. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600.
16. Hildesheim A, Wang SS (2002). Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229-240.
17. Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR (2006). Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 101:411-417
18. Kim JW, Lee CG, Park YG, Kim KS, Kim IK, Sohn YW, et al. (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88:2082-2091.
19. Lambropoulos AF, Agorastos T, Foka ZJ, Chrisafi S, Constantinidis TC, Bontis J, Kotsis A (2003). Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 191:187-191.
20. Li H, Huang CJ, Choo KB (2002). Expression of homeobox genes in cervical cancer. Gynecol Oncol 84:216-221.
21. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML (2000). Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epid Biomark Prev 9:1183-1191.
22. Sierra-Torres CH, AuWW, Arrastia CD, Cajas-Salazar N, Robazetti SC, Payne DA, Tyring SK (2003). Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen 41:69-76.
23. Thier R, Bruning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM (2003). Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health 206:149-171.
24. Warwick AP, Redman CW, Jones PW, Fryer AA, Gilford J, Alldersea J, Strange RC (1994a). Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione S transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer 70:704-708.
25. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, et al. (1994b). Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15:2841-2845.
26. Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, Tommasino M (2003). Association between human papillomavirus 16 E6 variants and human leukocyte antigen classI polymorphism in cervical cancer of Swedish women. Human Immunol 64:538-542.
27. Zoodsma M, Nolte IM, Meerman GTE, de Vries EGE, van der Zee AGJ (2005). HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease. Int J Oncol 26:769-784.